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Executive Summary
Title
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Author
Christina Wagener, MSN, Steve Kalish, MD, Mary Lee Barron, PhD, APRN, FNP-BC
Introduction of the Problem
An incidental finding of Actinomyces europaeus in a refractory healing abscess presents
an opportunity to close a knowledge and treatment protocol gap. After finding Actinomyces
species in multiple patients within a seven-month period in a wound care clinic in Chicago, IL,
the probability exists that A. europaeus is becoming more prevalent in subcutaneous wounds.
However, the diagnosis may be missed due to the complexity of testing and lack of knowledge
of this species in the differential diagnosis.
Literature Review
Actinomyces europaeus is a Gram-positive, filamentous, non-acid-fast and anaerobic-tomicroaerophilic bacteria that was originally identified in 1997 and found in the oropharynx and
reproductive track of females (White & Woolley, 2018; Funke, Englert, Frodl, Bernard &
Stenger, 2010). Typical wound cultures will miss Actinomyces bacterium because it is a rare
finding outside its’ normal habitat, length of time to grow and wound cultures traditionally not
including anaerobic testing (Kononen & Wade, 2015). Treatment guidelines from the Centers of
Disease Control for subcutaneous abscesses include incision, drainage and culturing; treatment
protocols do not include testing for Actinomyces (CDC, 2007). Treatment protocols for
Actinomyces europaeus are also unique because of the use of long-term penicillin, which is not

included in the current guidelines (Barberis et al., 2017; CDC, 2007; Ramakrishnan, Salinas &
Higuita, 2015; Sharkawy & Chow, 2018).
Project Methods
An educational quality improvement project on the identification, risk factors, testing,
and treatment for Actinomyces species was presented to clinicians in an independent hospital
in Chicago, Illinois. Pre- and post-education survey results, frequency of requests for
Actinomyces testing, and positive results were collected.
Evaluation
The primary outcome measurement was pre-and post-education assessment. As well as
the count of positive tests. This provided baseline knowledge or knowledge deficit of this
bacterium and then the post education understanding will allow for knowledge transfer and
understanding of both the bacterium, when to culture for the bacterium and protocols of
treatment. Volume of testing is in aggregate form, there is no patient data, no patient account
numbers, medical record numbers or diagnosis. All data will be evaluated using SPSS for
statistically evaluation.
Impact on Practice
A statistically significant educational outcome showed an increase in knowledge,
awareness, and identification of the appropriate testing and treatment protocols for refractory
wounds. Since October 2017, 17 specimens were cultured for Actinomyces; 41% (n=7) were
potisitve. These findings support that this is a clinically relevant bacteria to consider for
refractory wounds. Replication of this study on a larger scale is feasible with training and
automation of the ordering of this additional testing on wound cultures.

Conclusions
Actinomyces species may be prevalent in refractory wounds. Additional multi-site
studies as well as updating the treatment algorithm related to subcutaneous wounds/abscesses
should be considered.
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